Contraceptive provision to adolescent females prescribed teratogenic medications

Pediatrics

Volumn 137, Issue 1, 2016, Pages

  Stancil, Stephani L ^a,b   Miller, Melissa ^c,d   Briggs, Holley ^e   Lynch, Daryl ^a,d   Goggin, Kathy ^a,b,d   Kearns, Gregory ^b,f,g  

^a CHILDREN S MERCY HOSPITAL   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c Division of Pediatric Emergency Medicine   (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^e KANSAS CITY UNIVERSITY OF MEDICINE AND BIOSCIENCES   (United States)

^f ARKANSAS CHILDREN S HOSPITAL RESEARCH INSTITUTE   (United States)

^g UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; TERATOGENIC AGENT;

ADOLESCENT; ADULT; CONGENITAL MALFORMATION; CONTRACEPTION; COUNSELING; ELECTRONIC HEALTH RECORD; FEMALE; HUMAN; PREGNANCY; PRESCRIPTION; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; UNITED STATES; YOUNG ADULT;

ABNORMALITIES, DRUG-INDUCED; ADOLESCENT; ADULT; CONTRACEPTION; CONTRACEPTIVE AGENTS; COUNSELING; DRUG PRESCRIPTIONS; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; PREGNANCY; RETROSPECTIVE STUDIES; TERATOGENS; UNITED STATES; YOUNG ADULT;

EID: 84954156800     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2015-1454     Document Type: Article

References (16)

1. Schwarz EB, Postlethwaite DA, Hung Y-Y, Armstrong M.A. Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women. Ann Intern Med. 2007;147(6):370-376
2. Schwarz EB, Maselli J, Norton M, Gonzales R. Prescription of teratogenic medications in United States ambulatory practices. Am J Med. 2005;118(11):1240-1249
3. Pace LE, Schwarz EB. Balancing act: safe and evidence-based prescribing for women of reproductive age. Womens Health (Lond Engl). 2012;8(4):415-425
4. Fritsche MD, Ables AZ, Bendyk H. Opportunities missed: improving the rate of contraceptive counseling or provision when prescribing reproductive-aged women potentially teratogenic medications in a family medicine resident clinic. Contraception. 2011;84(4):372-376
5. De Santis M, Cesari E, Cavaliere A, et al. Paternal exposure and counselling: experience of a Teratology Information Service. Reprod Toxicol. 2008;26(1):42-46
6. Laffitte E. Thalidomide, semen distribution, teratogenicity.. and cost. Br J Dermatol. 2006;154(3):563, author reply 563-564
7. United States Food and Drug Administration. A brief overview of Risk Evaluation & Mitigation Strategies (REMS). Available at: http://www.fda.gov/downloads/AboutFDA/Transparency/Basics/UCM328784.pdf. Accessed April 15, 2015
8. Dean A, Sullivan K, Soe M. OpenEpi: open source epidemiologic statistics for public health, version 3.03.2010. Available at: http://www.openepi. Com. Accessed January 30, 2015
9. Lowry R. Vassarstats. Poughkeepsie, NY: Vassar College.). Available at: Vassarstats.net
10. Wiehe SE, Rosenman MB, Wang J, Katz BP, Fortenberry JD. Chlamydia screening among young women: individual-and provider-level differences in testing. Pediatrics. 2011;127(2). Available at: www.pediatrics.org/cgi/content/full/127/2/e336
11. Goyal MK, Witt R, Hayes KL, Zaoutis TE, Gerber JS. Clinician adherence to recommendations for screening of adolescents for sexual activity and sexually transmitted infection/human immunodeficiency virus. J Pediatr. 2014;165(2):343-347
12. Fiscus LC, Ford CA, Miller WC. Infrequency of sexually transmitted disease screening among sexually experienced U.S. Female adolescents. Perspect Sex Reprod Health. 2004;36(6):233-238
13. Kann L, Kinchen S, Shanklin SL, et al; Centers for Disease Control and Prevention (CDC). Youth risk behavior surveillance-United States, 2013. MMWR Surveill Summ. 2014;63(63, suppl 4):1-168
14. Miller MK, Mollen CJ, O'Malley D, et al. Providing adolescent sexual health care in the pediatric emergency department: views of health care providers. Pediatr Emerg Care. 2014;30(2):84-90
15. Committee on Adolescence. Contraception for adolescents. Pediatrics. 2014;134(4):e1244-e1256
16. US Food and Drug Administration, Department of Health and Human Services. Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling. December 2014.). Available at: https://www.federalregister.gov/articles/2014/12/04/2014-28241/content-and-format-of-labeling-for-human-prescription-drug-and-biological-products-requirements-for